Profil
Uday Shankarrao Patil is currently a Director at Keynote Commodities Ltd., Arteries Insurance Broking Ltd., Keynote Fincorp Ltd., Spire Investment & Trading Pvt Ltd., and an Associate at the Indian Institute of Banking & Finance.
He was previously an Independent Director at Vardhaman Laboratories Ltd. and served as the Chief Financial Officer & Executive Director at Keynote Financial Services Ltd. from 2013 to 2024.
Postes actifs de Uday Shankarrao Patil
| Sociétés | Poste | Début |
|---|---|---|
Arteries Insurance Broking Ltd. | Directeur/Membre du Conseil | 31/10/2011 |
Keynote Fincorp Ltd. | Directeur/Membre du Conseil | - |
Spire Investment & Trading Pvt Ltd. | Directeur/Membre du Conseil | - |
Indian Institute of Banking & Finance
Indian Institute of Banking & Finance Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Keynote Commodities Ltd. | Directeur/Membre du Conseil | 10/07/2017 |
Anciens postes connus de Uday Shankarrao Patil
| Sociétés | Poste | Fin |
|---|---|---|
| KEYNOTE FINANCIAL SERVICES LIMITED | Directeur Financier/CFO | 28/03/2024 |
| VARDHAMAN LABORATORIES LIMITED | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Keynote Financial Services Ltd.
Keynote Financial Services Ltd. Investment Banks/BrokersFinance Provides merchant banking services | Finance |
Indian Institute of Banking & Finance
Indian Institute of Banking & Finance Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keynote Commodities Ltd. | |
Arteries Insurance Broking Ltd. | |
Vardhaman Laboratories Ltd.
Vardhaman Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Keynote Fincorp Ltd. | |
Spire Investment & Trading Pvt Ltd. |
















